NEWS June 11, 2025 Galux and HanAll Biopharma Initiate Strategic Collaboration to Develop AI-Designed Antibody Therapeutics for Cancer Read More
INTERVIEW May 26, 2025 Pioneering Precision: How South Korea's Galux is Redefining Antibody Discovery with AI Read More
INTERVIEW March 20, 2025 [Interview] DeepMind predicted proteins. A Korean startup says it's designing the future of antibodies. Read More
INTERVIEW March 20, 2025 Korean AI firm Galux develops six novel therapeutic antibodies using innovative design methods Read More
NEWS March 17, 2025 Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets Read More
NEWS September 19, 2024 Galux Unveils Breakthrough AI Technology for Therapeutic Antibody Loop Design Read More
MEDIA August 26, 2024 Galux to conduct joint research with LG Chem on cancer drug development Read More
NEWS August 26, 2024 Galux and LG Chem Initiate Joint Research on AI-Powered Cancer Drug Development Read More
![[Interview] DeepMind predicted proteins. A Korean startup says it's designing the future of antibodies.](https://www.galux.co.kr/assets/images/newsroom/interview-1.png)
